Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

NCT00813046 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: gpASIT+TM

Sponsor

BioTech Tools S.A.